In surprise move, FDA rejects cancer drug expected to rival Novartis therapy
Allison covers what sizzling startups are getting as much as, and who’s financing them. She can be co-host of the ...
Tag: Rival
Processa Acquisition Lands Immunology Drug That Could Rival a New Novartis Product
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that provides pipeline-in-a-product potential addressing a goal ...
After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a uncommon autoimmune situation the ...
Selfish chromosomes hijack Overdrive gene to eliminate rival sperm
A brand new College of Utah-led examine has found the mechanism behind a decades-old evolutionary mystery-how "egocentric chromosomes" cheat the ...
Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med
Eli Lilly is expanding its pain drug pipeline with the acquisition of SiteOne Therapeutics, a startup whose lead program addresses ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!